Yazar "Ozdogan, Mustafa" için listeleme

Gelişmiş Arama

Toplam kayıt 4, listelenen: 1-4

Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK at 30 months of follow-up.

Sevinc, Alper; Turna, Hande; Ozdogan, Mustafa; Buyukberber, Suleyman; Demir, Gokhan; Gokmen, Erhan; Celik, Ismail (AMER SOC CLINICAL ONCOLOGY, 2013)

…
Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK.

Sevinc, Alper; Turna, Hande; Ozdogan, Mustafa; Buyukberber, Suleyman; Demir, Gokhan; Gokmen, Erhan; Celik, Ismail (AMER SOC CLINICAL ONCOLOGY, 2012)

…
Results of the Turkish prospective multi-center study utilizing the 21-gene Oncotype DX assay: Decision impact analysis.

Ozmen, Vahit; Atasoy, Ajlan; Gokmen, Erhan; Ozdogan, Mustafa; Guler, Emine Nilufer; Uras, Cihan; Saip, Pinar (AMER SOC CLINICAL ONCOLOGY, 2015)

…
Survival of the Patients With Breast Cancer Who Underwent Oncotype DX Recurrence Score Testing: Long-Term Survival Update of a Prospective Multicenter Study in Turkiye According to Different Cut-Offs

Ozkurt, Enver; Ordu, Cetin; Koc, Ertan; Gokmen, Erhan; Ozdogan, Mustafa; Guler, Nilufer; Uras, Cihan (Wiley, 2025)

Background: Seventy percent of early-stage breast cancers are hormone receptor positive. In this prospectively designed study, we aim to update the long-term survival outcomes of chemotherapy decision-making according to ...